Medetomidine a novel immobilizing agent for the elephant (Elephas maximus)

Area of Science:

• Veterinary Medicine
• Zoology
• Pharmacology

Background:

• Sedation protocols for large exotic animals like Indian elephants (Elephas maximus) require careful evaluation.
• Understanding the efficacy and safety of anesthetic agents is crucial for wildlife conservation and veterinary care.

Purpose of the Study:

• To evaluate the sedative effects of medetomidine in Indian elephants (Elephas maximus).
• To determine the onset, duration, and recovery parameters of medetomidine-induced sedation.
• To document physiological changes associated with medetomidine sedation in this species.

Main Methods:

• Two groups of Indian elephants (Elephas maximus) received intramuscular injections of medetomidine at 3 microg/kg and 5 microg/kg.
• Sedation onset, duration, and recovery times were recorded.
• Physiological parameters including heart rate, respiration, and body temperature were monitored.

Main Results:

• Sedation onset occurred rapidly, within approximately 6 minutes, for both dosage groups.
• The duration of anesthesia and recovery time were dose-dependent, with the higher dose (5 microg/kg) resulting in longer effects.
• Observed signs included penis protrusion, trunk relaxation, tail flaccidity, ear drooping, and head-down posture, accompanied by bradycardia, decreased respiration, and hypothermia.

Conclusions:

• Medetomidine is an effective sedative agent for Indian elephants (Elephas maximus).
• Dosage titration is important for managing the duration of sedation and recovery.
• The observed physiological changes are consistent with medetomidine's known effects and require careful monitoring during veterinary procedures.